TABLE 6.

Survival analysis of MYC mRNA in colon and rectal cancer patients (the PrognoScan).

Dataset	Endpoint	Number	ln(HRhigh/HRlow)	Cox P-value	ln(HR)	HR (95% CIlow–CIupp)
GSE12945-HG-U133_Plus_2	Disease-free survival	51	15.43	0.875782	0.09	1.09 (0.36–3.35)
	Overall survival	62	−15.38	0.647096	−0.16	0.86 (0.44–1.67)
GSE17536-HG-U133_Plus_2	Disease-free survival	145	−0.65	0.601886	−0.15	0.86 (0.50–1.50)
	Disease-free survival	145	−1.11	0.01759	−3.58	0.03 (0.00–0.54)
	Disease-specific survival	177	−0.97	0.115903	−0.36	0.70 (0.45–1.09)
	Overall survival	177	−0.73	0.216913	−0.24	0.78 (0.53–1.15)
	Overall survival	177	−0.64	0.021105	−2.34	0.10 (0.01–0.70)
	Disease-specific survival	177	−0.69	0.020065	−2.8	0.06 (0.01–0.64)
GSE14333-HG-U133_Plus_2	Disease-free survival	226	−0.44	0.272903	−0.23	0.79 (0.52–1.20)
	Disease-free survival	226	−0.67	0.52951	−0.1	0.90 (0.66–1.24)
GSE17537-HG-U133_Plus_2	Disease-free survival	55	−1.23	0.010481	−5.84	0.00 (0.00–0.25)
	Disease-specific survival	49	−1.81	0.043557	−5.94	0.00 (0.00–0.84)
	Overall survival	55	−0.65	0.823679	−0.06	0.94 (0.56–1.59)
	Overall survival	55	−2.11	0.001411	−7.34	0.00 (0.00–0.06)
	Disease-free survival	55	0.88	0.681468	0.13	1.14 (0.62–2.09)
	Disease-specific survival	49	−0.68	0.96835	−0.02	0.99 (0.47–2.07)